Invention Grant
US09011816B2 Fibronectin targeting contrast agent 有权
纤连蛋白靶向造影剂

Fibronectin targeting contrast agent
Abstract:
Example systems and methods enhance contrast in MRI images. To facilitate imaging of atherosclerotic plaques, arterial and venous, cardiac, and even tumor tissues and fibrosis, a fibrin-fibronectin complex or disease-related fibronectin specific MRI contrast agent (CLPD) has a specific binding affinity for fibronectin.
Public/Granted literature
Information query
Patent Agency Ranking
0/0